tiprankstipranks
Opus Genetics (IRD)
NASDAQ:IRD
Holding IRD?
Track your performance easily

Opus Genetics (IRD) Financial Statements

1,000 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently ―. The company's EPS TTM is $-1.086; its P/E ratio is -0.90; Opus Genetics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.87M$ 1.11M$ 1.71M$ 1.69M$ 11.94M
Gross Profit$ 3.87M$ 1.11M$ 1.71M$ 1.69M$ 11.94M
EBIT$ -7.53M$ -7.76M$ -7.11M$ -4.80M$ 5.58M
EBITDA$ -7.53M$ -7.76M$ -7.11M$ -4.79M$ 5.58M
Net Income Common Stockholders$ -7.53M$ -7.76M$ -7.11M$ -4.79M$ 5.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 36.60M$ 41.41M$ 47.20M$ 50.52M$ 42.41M
Total Assets$ 40.39M$ 44.83M$ 51.84M$ 53.95M$ 54.19M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -36.60M$ -41.41M$ -47.20M$ -50.52M$ -42.41M
Total Liabilities$ 6.09M$ 4.20M$ 5.79M$ 4.04M$ 3.91M
Stockholders Equity$ 34.30M$ 40.64M$ 46.06M$ 49.91M$ 50.28M
Cash Flow-
Free Cash Flow$ -5.13M$ -7.29M$ -5.72M$ 4.55M$ -3.00M
Operating Cash Flow$ -5.13M$ -7.29M$ -5.72M$ 4.55M$ -3.00M
Investing Cash Flow-----
Financing Cash Flow$ 353.00K$ 1.54M$ 2.38M$ 3.60M$ 5.38M
Currency in USD

Opus Genetics Earnings and Revenue History

Opus Genetics Debt to Assets

Opus Genetics Cash Flow

Opus Genetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis